Enzymes which control cell cycle progression, DNA replication and Pathway signaling can impact one key pathway called NF-κB (NF kappa B). This pathway is known to trigger the progression of multiple Myeloma. In laboratory studies, a new drug called TAS4464 showed it could stop myeloma cells from growing and kill myeloma cells. It is intended [...]
This post first appeared on Page Not Found - The Myeloma Crowd, please read the originial post: here
